Business · 21/06/2024Updated: 10/17/2026 · 1 min read
Sandoz Inc., et al.; FDA Withdraws Approval of 20 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 20 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications that the drug products were no longer being marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →